TScan Therapeutics, Inc. Profile Avatar - Palmy Investing

TScan Therapeutics, Inc.

TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic m…

Biotechnology
US, Waltham [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared TScan Therapeutics, Inc. (TCRX) to it's peer group.

Peer Group
ARWR APLS CGTX XFOR CUE DAWN TFFP ICVX ANNX TERN INZY ITOS DRMA ABOS Compare Together
Loading...
End of TCRX's Analysis
CIK: 1783328 CUSIP: 89854M101 ISIN: US89854M1018 LEI: - UEI: -
Secondary Listings
TCRX has no secondary listings inside our databases.